Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Behav Neurosci ; 131(4): 348-58, 2017 08.
Article in English | MEDLINE | ID: mdl-28714720

ABSTRACT

Caffeine is a psychostimulant frequently consumed by adults and children, often in combination with high levels of sugar. Chronic pretreatment with either substance can amplify both amphetamine and cocaine-induced hyperactivity in rodents. The present study sought to elucidate whether age at the time of exposure to sugar and/or caffeine alters sensitivity to an acute illicit psychostimulant (methamphetamine, [METH]) challenge in adulthood. Adult and adolescent (Postnatal Day 35 on first day of treatment) male Sprague-Dawley rats were treated for 26 days with water, caffeine (0.6 g/L), 10% sucrose or their combination. Locomotor behavior was measured on the first and last day of treatment. Following 9-days treatment free, animals were challenged with saline (1 ml/kg, i.p.) or METH (1 mg/kg, i.p.) and locomotor activity was measured. During the treatment period, adolescent rats maintained a higher caffeine (mg/kg) dose than their adult counterparts. Adding sugar to caffeine increased adolescent consumption and the highest caffeine dose consumed was measured in these animals. Drinking sugar-sweetened caffeinated water or combination did not produce cross-sensitization to METH administration in either age group. Nevertheless, the finding that regular exposure through adolescence to caffeinated sugar-sweetened beverages could increase consumption of caffeine and sugar later in life is important, as there is a large body of evidence that has linked excess consumption of sugar-sweetened beverages to a broad range of other negative physical and mental health outcomes. (PsycINFO Database Record


Subject(s)
Caffeine/adverse effects , Sugars/adverse effects , Age Factors , Animals , Caffeine/metabolism , Central Nervous System Stimulants/pharmacology , Dietary Sucrose/pharmacology , Locomotion/drug effects , Male , Methamphetamine/metabolism , Methamphetamine/pharmacology , Rats , Rats, Sprague-Dawley , Sugars/metabolism , Sweetening Agents/pharmacology
2.
Article in English | MEDLINE | ID: mdl-28351548

ABSTRACT

Schizophrenia is associated with significant pathophysiological changes to interneurons within the prefrontal cortex (PFC), with mRNA and protein changes associated with the GABA network localized to specific interneuron subtypes. Methamphetamine is a commonly abused psychostimulant that can induce chronic psychosis and symptoms that are similar to schizophrenia, suggesting that chronic METH induced psychosis may be associated with similar brain pathology to schizophrenia in the PFC. The aim of this study, therefore, was to examine mRNA expression of interneuron markers across two regions of the PFC (prelimbic (PRL) and orbitofrontal cortices (OFC)) following METH sensitization, an animal model of METH psychosis. We also studied the association between GABA mRNA expression and interneuronal mRNA expression to identify whether particular changes to the GABA network could be localized to a specific inhibitory cellular phenotype. METH sensitization increased the transcriptional expression of calbindin, calretinin, somatostatin, cholecyctokinin and vasoactive intestinal peptide in the PRL while parvalbumin, calbindin, cholectokinin and vasoactive intestinal peptide were upregulated in the OFC. Based on our previous findings, we also found significant correlations between GAD67, GAT1 and parvalbumin while GAD67, GAD65 and GAT1 were positively correlated with cholecystokinin in the PRL of METH sensitized rats. Within the OFC, the expression of GABAAα1 was positively correlated with somatostatin while GABAAα5 was negatively associated with somatostatin and calbindin. These findings suggest that METH sensitization differentially changes the expression of mRNAs encoding for multiple peptides and calcium binding proteins across the PRL and the OFC. Furthermore, these findings support that changes to the GABA network may also occur within specific cell types. These results, therefore, provide the first evidence that METH sensitization mediates differential interneuronal pathology across the PRL and OFC and such changes could have profound consequences on behavior and cognitive output.


Subject(s)
Central Nervous System Sensitization , Interneurons/metabolism , Interneurons/pathology , Limbic Lobe/metabolism , Methamphetamine/pharmacology , Prefrontal Cortex/metabolism , RNA, Messenger/metabolism , Animals , GABA Plasma Membrane Transport Proteins/metabolism , Glutamate Decarboxylase/metabolism , Limbic Lobe/pathology , Nerve Tissue Proteins/metabolism , Peptides/metabolism , Prefrontal Cortex/pathology , Rats , Receptors, GABA-A/biosynthesis , gamma-Aminobutyric Acid/metabolism
3.
Proteomics ; 16(22): 2894-2910, 2016 11.
Article in English | MEDLINE | ID: mdl-27588558

ABSTRACT

Caffeine is a psychostimulant commonly consumed with high levels of sugar. The increased availability of highly caffeinated, high sugar energy drinks could put some consumers at risk of being exposed to high doses of caffeine and sugar. Notably, research that has examined the consequences of this combination is limited. Here, we explored the effect of chronic exposure to caffeine and/or sugar on behavior and protein levels in the orbitofrontal cortex (OFC) of rats. The OFC brain region has been implicated in neuropsychiatric conditions, including obesity and addiction behaviors. Adult male Sprague-Dawley rats were treated for 26 days with control, caffeine (0.6 g/L), 10% sugar, or combination of both. Locomotor behavior was measured on the first and last day of treatment, then 1 week after treatment. Two hours following final behavioral testing, brains were rapidly removed and prepared for proteomic analysis of the OFC. Label-free quantitative shotgun analysis revealed that 21, 12, and 23% of proteins identified in the OFC were differentially expressed by sugar and/or caffeine. The results demonstrate that the intake of high levels of sugar and/or low to moderate levels of caffeine has different behavioral consequences. Moreover, each treatment results in a unique proteomic profile with different implications for neural health.


Subject(s)
Caffeine/pharmacology , Central Nervous System Stimulants/pharmacology , Dietary Carbohydrates/pharmacology , Prefrontal Cortex/drug effects , Proteome/metabolism , Animals , Behavior, Animal/drug effects , Beverages/adverse effects , Caffeine/adverse effects , Central Nervous System Stimulants/adverse effects , Dietary Carbohydrates/adverse effects , Locomotion/drug effects , Male , Prefrontal Cortex/physiology , Proteome/analysis , Proteomics , Rats, Sprague-Dawley , Signal Transduction/drug effects , Weight Gain/drug effects
4.
Neuropharmacology ; 111: 107-118, 2016 12.
Article in English | MEDLINE | ID: mdl-27580848

ABSTRACT

Psychotic disorders, such as schizophrenia, are characterized by prevalent and persistent executive deficits that are believed to be the result of dysfunctional inhibitory gamma-aminobutyric acid (GABA) processing of the prefrontal cortex (PFC). Methamphetamine (METH) is a commonly used psychostimulant that can induce psychotic and cognitive symptoms that are indistinguishable to schizophrenia, suggesting that METH-induced psychosis may have a similar GABAergic profile of the PFC. As the PFC consists of multiple subregions, the aim of the current study was to investigate changes to GABAergic mRNA expression in the prelimbic (PRL) and orbitofrontal (OFC) cortices of the PFC in rats sensitized to repeated METH administration. Male Sprague Dawley rats underwent daily METH or saline injections for 7 days. Following 14 days of withdrawal, rats were challenged with acute METH administration, RNA was isolated from the PRL and OFC and quantitative PCR was used to compare the relative expression of GABA enzymes, transporters, metabolites and receptor subunits. GAD67, GAD65, GAT1, GAT3, VGAT and GABAT mRNA expression were upregulated in the PRL. Ionotropic GABAA receptor subunits α1, α3, α5 and ß2 were specifically upregulated in the OFC. These findings suggest that alterations to GABAergic mRNA expression following sensitization to METH are biologically dissociated between the OFC and PRL, suggesting that GABAergic gene expression is significantly altered following chronic METH exposure in a brain-region and GABA-specific manner. These changes may lead to profound consequences on central inhibitory mechanisms of localized regions of the PFC and may underpin common behavioral phenotypes seen across psychotic disorders.


Subject(s)
Methamphetamine/administration & dosage , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Psychotic Disorders/metabolism , Receptors, GABA/metabolism , gamma-Aminobutyric Acid/metabolism , Animals , GABA Plasma Membrane Transport Proteins/metabolism , Glutamate Decarboxylase/metabolism , Male , Motor Activity/drug effects , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Vesicular Inhibitory Amino Acid Transport Proteins/metabolism
5.
J Proteome Res ; 15(5): 1455-71, 2016 05 06.
Article in English | MEDLINE | ID: mdl-26941107

ABSTRACT

Caffeine is a plant-derived psychostimulant and a common additive found in a wide range of foods and pharmaceuticals. The orbitofrontal cortex (OFC) is rapidly activated by flavours, integrates gustatory and olfactory information, and plays a critical role in decision-making, with dysfunction contributing to psychopathologies and neurodegenerative conditions. This study investigated whether long-term consumption of caffeine causes changes to behavior and protein expression in the OFC. Male adult Sprague-Dawley rats (n = 8 per group) were treated for 26 days with either water or a 0.6 g/L caffeine solution. Locomotor behavior was measured on the first and last day of treatment, then again after 9 days treatment free following exposure to a mild stressor. When tested drug free, caffeine-treated animals were hyperactive compared to controls. Two hours following final behavioral testing, brains were rapidly removed and prepared for proteomic analysis of the OFC. Label free shotgun proteomics found 157 proteins differentially expressed in the caffeine-drinking rats compared to control. Major proteomic effects were seen for cell-to-cell communication, cytoskeletal regulation, and mitochondrial function. Similar changes have been observed in neurological disorders including Alzheimer's disease, Parkinson's disease, and schizophrenia.


Subject(s)
Caffeine/pharmacology , Gene Expression Regulation/drug effects , Prefrontal Cortex/chemistry , Proteomics/methods , Animals , Cell Communication/drug effects , Cytoskeleton/drug effects , Gene Expression Profiling , Male , Mitochondria/drug effects , Motor Activity/drug effects , Nervous System Diseases/metabolism , Rats , Rats, Sprague-Dawley
6.
Proteomics ; 16(4): 657-73, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26621205

ABSTRACT

In most Westernized societies, there has been an alarming increase in the consumption of sugar-sweetened drinks. For many adults these drinks represent a substantial proportion of their total daily caloric intake. Here we investigated whether extended exposure to sugar changes behavior and protein expression in the orbitofrontal cortex (OFC). Male adult Sprague-Dawley rats (n = 8 per group) were treated for 26 days with either water or a 10% sucrose solution. Locomotor behavior was measured on the first and last day of treatment, then 1 week after treatment. Following the 1-week period free from treatment, sucrose treated rats were significantly more active than the control. Two hours following final behavioral testing, brains were rapidly removed and prepared for proteomic analysis of the OFC. Label free quantitative shotgun proteomic analyses of three rats from each group found 290 proteins were differentially expressed in the sucrose treated group when compared to the control group. Major changes in the proteome were seen in proteins related to energy metabolism, mitochondrial function and the cellular response to stress. This research does not seek to suggest that sugar will cause specific neurological disorders, however similar changes in proteins have been seen in neurological disorders such as Alzheimer's disease, Parkinson's disease and schizophrenia.


Subject(s)
Prefrontal Cortex/metabolism , Proteome/metabolism , Sucrose/metabolism , Animals , Carbohydrate Metabolism , Carbonated Beverages/adverse effects , Energy Intake , Energy Metabolism , Glucose/metabolism , Male , Mitochondria/metabolism , Motor Activity , Oxidative Stress , Prefrontal Cortex/physiology , Proteome/analysis , Proteomics , Rats , Rats, Sprague-Dawley , Sucrose/adverse effects , Weight Gain
7.
Behav Brain Res ; 297: 224-30, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26475507

ABSTRACT

Inhibitory gamma-aminobutyric acid (GABA)-mediated neurotransmission plays an important role in the regulation of the prefrontal cortex (PFC), with increasing evidence suggesting that dysfunctional GABAergic processing of the PFC may underlie certain deficits reported across psychotic disorders. Methamphetamine (METH) is a psychostimulant that induces chronic psychosis in a subset of users, with repeat administration producing a progressively increased vulnerability to psychotic relapse following subsequent drug administration (sensitization). The aim here was to investigate changes to GABAergic mRNA expression in the PFC of rats sensitized to METH using quantitative polymerase chain reaction (qPCR). Male Sprague-Dawley rats (n=12) underwent repeated methamphetamine (intraperitoneal (i.p.) or saline injections for 7 days. Following 14 days of withdrawal, rats were challenged with acute methamphetamine (1mg/kg i.p.) and RNA was isolated from the PFC to compare the relative mRNA expression of a range of GABA enzymes, transporters and receptors subunits. METH challenge resulted in a significant sensitized behavioral (locomotor) response in METH pre-treated animals compared with saline pre-treated controls. The mRNAs of transporters (GAT1 and GAT3), ionotropic GABAA receptor subunits (α3 and ß1), together with the metabotropic GABAB1 receptor, were upregulated in the PFC of sensitized rats compared with saline controls. These findings indicate that GABAergic mRNA expression is significantly altered at the pre and postsynaptic level following sensitization to METH, with sensitization resulting in the transcriptional upregulation of several inhibitory genes. These changes likely have significant consequences on GABA-mediated neurotransmission in the PFC and may underlie certain symptoms conserved across psychotic disorders, such as executive dysfunction.


Subject(s)
Central Nervous System Stimulants/pharmacology , Methamphetamine/pharmacology , Prefrontal Cortex/drug effects , gamma-Aminobutyric Acid/metabolism , Animals , GABA Plasma Membrane Transport Proteins/metabolism , Male , Motor Activity/drug effects , Neurons/drug effects , Neurons/metabolism , Polymerase Chain Reaction , Prefrontal Cortex/metabolism , RNA, Messenger/metabolism , Rats, Sprague-Dawley , Receptors, GABA-A/metabolism , Receptors, GABA-B/metabolism , Up-Regulation/drug effects
8.
J Proteome Res ; 14(1): 397-410, 2015 Jan 02.
Article in English | MEDLINE | ID: mdl-25245100

ABSTRACT

Repeat administration of psychostimulants, such as methamphetamine, produces a progressive increase in locomotor activity (behavioral sensitization) in rodents that is believed to represent the underlying neurochemical changes driving psychoses. Alterations to the prefrontal cortex (PFC) are suggested to mediate the etiology and maintenance of these behavioral changes. As such, the aim of the current study was to investigate changes to protein expression in the PFC in male rats sensitized to methamphetamine using quantitative label-free shotgun proteomics. A methamphetamine challenge resulted in a significant sensitized locomotor response in methamphetamine pretreated animals compared to saline controls. Proteomic analysis revealed 96 proteins that were differentially expressed in the PFC of methamphetamine treated rats, with 20% of these being previously implicated in the neurobiology of schizophrenia in the PFC. We identified multiple biological functions in the PFC that appear to be commonly altered across methamphetamine-induced sensitization and schizophrenia, and these include synaptic regulation, protein phosphatase signaling, mitochondrial function, and alterations to the inhibitory GABAergic network. These changes could inform how alterations to the PFC could underlie the cognitive and behavioral dysfunction commonly seen across psychoses and places such biological changes as potential mediators in the maintenance of psychosis vulnerability.


Subject(s)
Central Nervous System Sensitization/drug effects , Methamphetamine/adverse effects , Prefrontal Cortex/metabolism , Proteome/metabolism , Psychotic Disorders/physiopathology , Synapses/metabolism , Animals , Chromatography, Liquid , Databases, Protein , Electrophoresis, Polyacrylamide Gel , Male , Models, Neurological , Prefrontal Cortex/drug effects , Proteome/drug effects , Psychotic Disorders/metabolism , Rats , Synapses/drug effects , Tandem Mass Spectrometry
SELECTION OF CITATIONS
SEARCH DETAIL
...